On June 14, Gelunhui reported that Sihuan Pharm (00460.HK) had entrusted a trustee to purchase a total of 5 million shares of company stock on the market at an average cost of approximately HKD 0.5450 per share as part of its stock incentive plan, which was to be completed by June 14, 2024.
四环医药(00460.HK)：受托人根据股份奖励计划购买合共500万股公司股份
Sihuan Pharm (00460.HK): The trustee purchases a total of 5 million shares of the company's stock according to the stock incentive plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.